article · Malaria Journal

Incidence and trends of adverse drug reactions during seasonal malaria chemoprevention among children: evidence from Ghana’s pharmacovigilance database, 2015–2023

Benjamin Akwasi Forkuo Otoo
George Tsey Sabblah
Seth Kwaku Seaneke
Delese Mimi Darko
Michael Opoku-Mireku
Harriet Affran Bonful

2026Open accessCatholic University College of Ghana

Abstract

SMC with SPAQ is generally safe in Ghana, though serious ADRs continue to occur. The low reporting rate by healthcare professionals, contrasted with high reporting by caregivers, underscores the need to enhance professional engagement, ensure accurate community reporting, and expand active surveillance during SMC campaigns.

Research topics

Pharmacovigilance and Adverse Drug Reactions
Malaria Research and Control
Pharmaceutical Quality and Counterfeiting

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1186/s12936-026-05851-x

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.